MARGIT BATIZY: Open Payments
NPI 1194155184 · MEDINA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$926 in 41 payments from 11 companies in 2025. Trend: 2023 $45 · 2024 $1,216 · 2025 $926
Food & beverage: $926
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $355 |
| Aimmune Therapeutics, Inc. | 5 | $97 |
| QOL Medical, LLC | 4 | $90 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $73 |
| VIVUS LLC | 3 | $56 |
| Ardelyx, Inc. | 3 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $53 |
| Celltrion USA Inc. | 2 | $43 |
| Phathom Pharmaceuticals, Inc. | 3 | $41 |
| Janssen Biotech, Inc. | 2 | $41 |
Products named: RINVOQ, Sucraid, ZENPEP, XIFAXAN, LINZESS, QSYMIA, IBSRELA, ENTYVIO.
Industry payments across OH — which companies pay providers there.
